[1] A. J .Hutt, J. Caldwell, “The importance of stereochemistry in the clinical pharmacokinetics of the 2-arylpropionic acid non-steroidal anti-inflammatory drugs,” Clinical Pharmacokinetics, 9, 371-373, 1984.
[2] B. A. Hendriksen, J. D. Williams, “Characterization of calcium fenoprofen 2. Dissolution from formulated tablets and compressed rotating discs,” International journal of pharmaceutics, 69, 175-180, 1991.
[3] C. Patrono, G. Ciabattoni, D. Grossi-Belloni, “In vitro and in vivo inhibition of prostaglandin synthesis by fenoprofen, a non-steroid anti-inflammatory drug,” Pharmacological research communications, 6, 509-518, 1974.
[4] S. Abramson, H. Korchak, R. Ludewig, H. Edelson, K. Haines, R. I. Levin, R. Herman, L. Rider, S. Kimmel, G. Weissmann, “Modes of action of aspirin-like drugs,” Proceedings of the national academy of sciences, 82, 7227-7231, 1985.
[5] F. J. de Abajo, M. J. Gil, V. Bryant, J. Timoner, B. Oliva, L. A. García-Rodríguez, “Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case–control study in a new general practice database, ” European journal of clinical pharmacology, 69, 691-701, 2013.
[6] H. Okanobu, M. Ito, S. Tanaka, S. Onogawa, M. Akagi, H. Oh-e, S. Nagata, S. Okamoto, T. Kuwai, S. Cho, Y. Matsumoto, “Evaluation of individual risk in nonvariceal gastrointestinal bleeding patients with NSAID administration: a multicenter study in Japan,” Digestion, 86, 187-193, 2012.
[7] S. S. Adams, P. Bresloff, C. G. Mason, “Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer,” Journal of pharmacy and pharmacology, 28, 256-257, 1976.
[8] A. J. Hutt, J. Caldwell, “The metabolic chiral inversion of 2-arylpropionic acids- a novel route with pharmacological consequences,” Journal of pharmacy and pharmacology, 35, 693-704, 1983.
[9]Z. N. Gaut, H. Baruth, L. O. Randall, C. Ashley, J. R. Paulsrud, “Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthesis,” Prostaglandins, 10, 59-66, 1975.
[10] A. P. Roszkowski, W. H. Rooks, A. J. TOMOLONIS, L. M. MILLER, “Anti-inflammatory and analgetic properties of d-2-(6'-methoxy-2'-naphthyl)-propionic acid (naproxen),” Journal of Pharmacology and Experimental Therapeutics, 179, 114-123, 1971.
[11] A. Rubin, M. P. Knadler, P. P. Ho, L. D. Bechtol, R. L. Wolen, “Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans,” Journal of pharmaceutical sciences, 74, 82-84, 1985.
[12] A. M. Evans, “Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs,” European journal of clinical pharmacology, 42, 237-256, 1992.
[13] C. Volland, H. Sun, L. Z. Benet, “Stereoselective analysis of fenoprofen and its metabolites,” Journal of Chromatography B, Biomedical sciences and applications, 534, 127-138, 1990.
[14] S. D. Hall, M. Hassanzadeh‐Khayyat, M. P. Knadler, P. R. Mayer, “Pulmonary inversion of 2‐arylpropionic acids: influence of protein binding,” Chirality, 4, 349-352, 1992.
[15] B. W. Berry, F. Jamali, “Presystemic and systemic chiral inversion of R-(-)-fenoprofen in the rat,” Journal of Pharmacology and experimental therapeutics, 258, 695-701, 1991.
[16] G. Geisslinger, O. Schuster, K. P. Stock, D. Loew, G. L. Bach, K. Brune, “Pharmacokinetics of S (+)-and R (−)-ibuprofen in volunteers and first clinical experience of S (+)-ibuprofen in rheumatoid arthritis,” European journal of clinical pharmacology, 38, 493-497, 1990.
[17] S. Sundaram, R. Jayaprakasam, M. Dhandapani, T. S. Senthil, V. N. Vijayakumar, “Theoretical (DFT) and experimental studies on multiple hydrogen bonded liquid crystals comprising between aliphatic and aromatic acids,” Journal of molecular liquid, 243, 14-21, 2017.
[18] A. H. Mashhadzadeh, A. M. Vahedi, M. Ardjmand, M. G. Ahangari, “Investigation of heavy metal atoms adsorption onto graphene and graphdiyne surface: a density functional theory study,” Superlattices and microstructures, 100, 1094-1102, 2016.
[19] S. Hadidi, F. Shiri, M. Norouzibazaz, “Mechanistic study of fenoprofen photoisomerization to pure (S)-fenoprofen: a DFT study,” Structural chemistry, 31, 115-122, 2020.
[20] K. Dermeche, N. Tchouar, D. Harkati, S. Belaidi, K. Bentayeb, A. Rouane, “Molecular modeling of reactivity and vibrational spectrum raman of thalidomide enantiomers R and S using density functional theory and hartree-fock methods,” Quantum matter, 6, 1-7, 2017.
[21] E. Soleymani, H. Alinezhad, M. Darvish. G, M. Tajbakhsh, “Enantioseparation performance of CNTs as chiral selectors for the separation of ibuprofen isomers: a dispersion corrected DFT study,” Journal of materials chemistry B, 5, 6920-6929, 2017.
[22] A. Szabo, N. S. Ostlund, “Modern quantum chemistry: introduction to advanced electronic structure theory,” Courier corporation, 2012.
[23] P. W. Atkins, R. S. Friedman, “Molecular quantum mechanics,” 5th edition. Oxford university press, 2011.
[24] D. W. Rogers, “Computational Chemistry using the PC,” John wiley & sons, 2003.
[25] M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, “Gaussian 09,” Gaussian. inc, wallingford, CT, 32, 5648-5652, 2009.
[26] E. D. Glendening, C. R. Landis, F. Weinhold, “NBO 6.0: Natural bond orbital analysis program,” Journal of computational chemistry, 34, 1429-1437, 2013.
[27] P. Politzer, J. M. Seminario, editors, “Modern density functional theory: a tool for chemistry,” Elsevier, 2, 405, 1995.
[28] H. O. Ammar, T. S. Makram, S. Mosallam, “Effect of polymers on the physicochemical properties and biological performance of fenoprofen calcium dihydrate-triacetyl-β-cyclodextrin complex,” Pharmaceutics, 9, 23, 2017.
[29] S. Murthy-patnala, M. Khagga, R. bhavani, “Monotropically more stable fenoprofen calcium dihydrate,” Journal of applicable chemistry, 4, 895-902, 2015.
[30] S. H. Sarijo, M. L. Jadam, F. M. Saleh, “Intercalation of fenoprofen into layered double hydroxide for the formation of controlled release anti-inflammatory drug,” Advanced materials research, 1142, 230-233, 2017.
[31] A. D. Becke, “Density functional thermochemistry. I. The effect of the exchange only gradient correction,” The journal of chemical physics, 96, 2155-2160, 1992.
[32] J. E. Carpenter, F. Weinhold, “Analysis of the geometry of the hydroxymethyl radical by the “different hybrids for different spins” natural bond orbital procedure,” Journal of molecular structure, Theochem, 169, 41-62, 1988.
[33] A. Lesarri, A. Vega-Toribio, R. D. Suenram, D. J. Brugh, D. Nori-Shargh, J. E. Boggs, J. U. Grabow, “Structural evidence of anomeric effects in the anesthetic isoflurane,” Physical chemistry chemical physics, 13, 6610-6618, 2011.
[34] N. Masnabadi, D. Nori-Shargh, F. Azarakhshi, H. Zamani Ganji, M. Abbasi, S. Karamad, G. A. Kasaei, “Hybrid-DFT, MO study and NBO interpretation of conformational behaviors of 2-halo-1, 3-dioxanes and their dithiane and diselenane analogs,” Phosphorus sulfur silicon relat elem, 187, 305-320, 2012.
[35] S. Muthu, N. R. Sheela, S. Sampathkrishnan, “Density functional theory and ab initio studies of vibrational spectra of 2-bis (2-chloroethyl) aminoperhydro-1,3,2-oxazaphosphorinane-2-oxide,” Molecular simulation, 37, 1276-1288, 2011.
[36] S. Hadidi, F. Shiri, M. Norouzibazaz and Farshad Shiri, “A theoretical investigation of the flurbiprofen methyl ester isomerization as the main step in the photopreparation of anti-inflammatory medicine (S)-flurbiprofen: A DFT study”, Current Chemistry Letters, 9, 161–170, 2020.
[37] M. Kwiatkowska, A. Wzorek, A. Kolbus, M. Urbaniak, J. Han, V.A. Soloshonok, K.D. Klika, “Flurbiprofen: A Study of the Behavior of the Scalemate by Chromatography, Sublimation, and NMR”, Symmetry, 13, 543, 2021.